Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced that management will participate at the 2023 Cantor Global Healthcare Conference, taking place September 26-28, 2023, in New York, NY.
Todd Harris, CEO of TYRA, will participate in a fireside chat on Wednesday, September 27, 2023, at 10:20 am ET.
A live and archived webcast of the fireside chat will be available via the For Investors page on the Investor section of the TYRA website.
